Mr. Assaf Barnea is a seasoned entrepreneur and venture professional, with extensive, multidisciplinary
experience in building innovation platforms and leading commercialization processes in healthcare. He leads
Sanara Ventures, a healthcare innovation fund backed by Phillips and Teva.
In addition to leading Sanara, Mr. Barnea chairs the Life Science Advisory Board at The Israel Export Institute,
on behalf of the Israeli government, promoting and advancing the export of Israeli technologies in the medical,
biotech, pharma and digital fields in global markets. A valued consultant, Mr. Barnea also advises the World
Bank’s IFC venture capital team and is a co-founder of the IFC’s Tech Emerge initiative; a unique acceleration
platform that connects healthcare startups from around the world with leading corporations and hospitals in
emerging economies. On December 2018, Tech Emerge Health has won the world bank group president’s
award for innovation.
Formerly, Mr. Barnea was one of the founders of CardioSense, a medtech startup company that developed a
probe for early shock detection in various medical settings.
Before lending his multidisciplinary acumen to Sanara Ventures, Assaf served as CEO of Kinrot Ventures,
spearheading its acquisition by Hutchison Water in 2012. Prior to this, he headed business development at
Mekorot, Israel’s national water company, where he oversaw the establishment of WaTech, the Entrepreneurship
& Partnership Center for Water Technologies. For his accomplishments in both Mekorot and Kinrot, he
received the Cleantech Group’s Innovation Hero Award in April 2013, which recognizes individuals whose
commitment, drive and passion have made a tangible difference for innovation in general and specifically formany start-up companies.
Assaf is attending / has attended:
VSVC West 2021
Venture Summit Virtual Connect | Global 21